DISCERN™ is the world’s only NIH Gold Standard validated test that identifies and distinguishes Alzheimer’s disease from non-Alzheimer’s Dementia. The test requires a small skin sample, which is used to analyze three biophysical and biochemical measures to detect Alzheimer’s disease pathology. The test assesses the morphology of skin fibroblasts, Protein Kinase C, and phosphorylated extracellular regulated kinase ratios using a high sensitive single-molecule array from a single sample of skin.
It is your decision as a healthcare provider to have your patient take the DISCERN™ test. You can determine if it’s the right test for your patient based on your patient’s Dementia diagnosis and your assessment.
The DISCERN™ test may be necessary for a patient with a family history of Alzheimer’s as it will determine if they have it or not.
More than a decade of clinical research has shown 3 key proprietary biomarkers that determine the level of synaptic loss in the brain before the onset of amyloid plaques or tangles and even in the early stages of progression (between 0 to 4 years).
You or your administrative staff may also call us to discuss setting up an account. Once we receive your information and confirm information about your office, your account will be established, and a customer service representative will contact you to schedule the delivery of your test kit.
Once a lab appointment has been scheduled for your patient, your office (or the lab facility collecting the skin sample) will receive the test kit before the day of the appointment. The test kit will include specific instructions for the biopsy collection and processing.
If your office does not offer skin punch biopsy, you’ll need to contact us, and we will do our best to locate a DISCERN™ certified doctor with the ability to provide that service.
We will send an official lab report directly to you.
DISCERN™ test results are highly accurate both detecting Alzheimer’s disease and differentiating it from other types of Dementia. This test is backed by more than a decade of research.
Please refer to the benefits of an early diagnosis page here.
The Resources page provides comprehensive information and local and national resources for individuals to learn more about Alzheimer’s disease. If your office does not have social services available to counsel your patient, you may consider referring your patient to your local Alzheimer’s Association chapter or your State’s Office of Aging.
Input your search keywords and press Enter.